Leerink Partnrs Lowers Earnings Estimates for Ardent Health

Key Points

• Leerink Partners has reduced their fiscal year 2025 EPS estimate for Ardent Health from $2.01 to $1.75, indicating a significant downward adjustment in earnings expectations.
• Ardent Health recently reported a quarterly EPS of $0.52, exceeding the consensus estimate of $0.30, along with revenue of $1.65 billion which also surpassed expectations.
• Analyst ratings vary, with several analysts maintaining an "overweight" rating while others have issued lower target prices, leading to a consensus rating of "Moderate Buy" for the stock.

Ardent Health, Inc. (NYSE:ARDT - Free Report) - Investment analysts at Leerink Partnrs dropped their FY2025 earnings estimates for shares of Ardent Health in a research note issued to investors on Wednesday, August 6th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of $1.75 for the year, down from their previous forecast of $2.01. The consensus estimate for Ardent Health's current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health's Q4 2025 earnings at $0.58 EPS, Q1 2026 earnings at $0.39 EPS, Q2 2026 earnings at $0.53 EPS, Q3 2026 earnings at $0.47 EPS, Q4 2026 earnings at $0.64 EPS, FY2026 earnings at $2.04 EPS, FY2027 earnings at $2.28 EPS and FY2028 earnings at $2.55 EPS.

Ardent Health (NYSE:ARDT - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.22. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.54 billion.

Several other equities analysts also recently weighed in on the stock. Stephens reiterated an "overweight" rating and issued a $21.00 price target on shares of Ardent Health in a report on Tuesday, May 20th. Wall Street Zen upgraded shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a report on Saturday. Bank of America cut shares of Ardent Health from a "neutral" rating to an "underperform" rating and dropped their price objective for the stock from $15.50 to $14.60 in a research note on Wednesday, July 16th. Guggenheim lifted their target price on shares of Ardent Health from $16.00 to $18.00 and gave the company a "buy" rating in a report on Friday, May 9th. Finally, KeyCorp cut their target price on shares of Ardent Health from $24.00 to $20.00 and set an "overweight" rating for the company in a report on Thursday, August 7th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Ardent Health presently has an average rating of "Moderate Buy" and an average price target of $19.55.

Ardent Health Stock Performance

NYSE:ARDT traded up $0.31 during midday trading on Friday, hitting $12.35. The company's stock had a trading volume of 224,214 shares, compared to its average volume of 405,318. Ardent Health has a fifty-two week low of $10.10 and a fifty-two week high of $20.72. The firm's 50 day moving average is $12.63 and its 200-day moving average is $13.44. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 2.00. The firm has a market cap of $1.77 billion and a P/E ratio of 6.86.

Institutional Investors Weigh In On Ardent Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Oliver Luxxe Assets LLC boosted its stake in Ardent Health by 1.5% during the 2nd quarter. Oliver Luxxe Assets LLC now owns 87,639 shares of the company's stock worth $1,197,000 after purchasing an additional 1,319 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Ardent Health during the 4th quarter valued at about $27,000. Geode Capital Management LLC boosted its position in shares of Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company's stock valued at $3,918,000 after acquiring an additional 1,769 shares during the last quarter. Squarepoint Ops LLC boosted its position in shares of Ardent Health by 1.8% during the 4th quarter. Squarepoint Ops LLC now owns 101,798 shares of the company's stock valued at $1,739,000 after acquiring an additional 1,798 shares during the last quarter. Finally, CWM LLC boosted its position in shares of Ardent Health by 990.6% during the 2nd quarter. CWM LLC now owns 2,203 shares of the company's stock valued at $30,000 after acquiring an additional 2,001 shares during the last quarter.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.